相关实验视频

Updated: Sep 18, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

工程外体用于向的微RNA输送,以逆转肝纤维化

Huan Zhang¹, Jianming Xing¹, Man Sun¹

¹School of Life Sciences, Jilin University, Changchun, 130012, China.

|June 25, 2025

概括

工程外体有效地传递microRNA-29b以向肝纤维化,克服药物传递的挑战,并抑制激活的肝星细胞以提高抗纤维菌疗效.

科学领域:

生物医学工程生物医学工程
药物输送系统药物输送系统
肝病学肝病学是一种肝病学.

背景情况:

核酸药物对肝纤维化有希望,但在细胞外基质透和向激活肝星细胞 (aHSCs) 方面面临挑战.
外体体 (Exos) 是潜在的药物载体,但临床使用受到低产量,药物载荷能力和输送效率的限制.

研究的目的:

开发一种高通量生产工程外体的高通量方法,用于向性肝纤维化治疗.
为了研究装载微RNA-29b (miR-29b) 的工程外体的疗效,用于治疗肝纤维化.

主要方法:

一个纳秒脉冲微流体系统 (T-nsPMs) 用于高通量外体细胞的生产.
用5HT1D抗体和CD47蛋白 (TCMExos) 设计出外体,以有针对性地输送miR-29b.
在体外和体外模型被用于评估ECM透率,aHSC的向和抗纤维效应.

主要成果:

TCMExos成功地透了ECM,避免了巨细胞化,并准aHSCs,将miR-29b传递到纤维化部位.
用TCMExos治疗显著降低了关键激活标记 (α-SMA,COL1A1,TIMP-1,p-SMAD2) 和减少了原沉积.
机理学研究证实TCMExos抑制TGF-β/SMAD信号通路,显示出强大的抗纤维菌活性.

结论:

工程 TCMExos 为肝纤维化治疗提供了一个高效和有针对性的纳米级药物输送系统.
这种方法克服了当前核酸疗法和基于外体的药物输送的局限性.
这项研究提出了一种新的策略,用于提高肝纤维化治疗结果.

关键词:

药物输送系统是药物输送系统.外基因组是外基因组的组成部分.肝脏纤维化肝脏纤维化微流体技术的微流体技术核酸药物核酸药物是一种药物.

更多相关视频

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...